DCB-BO1301

· Chung Mei Biopharma Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCB-BO1301, covering 2022-03-18 to 2022-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of DCB-BO1301 in Advanced Melanoma [Phase 1, Phase 2]